全文获取类型
收费全文 | 4012篇 |
免费 | 241篇 |
国内免费 | 206篇 |
出版年
2023年 | 67篇 |
2022年 | 81篇 |
2021年 | 89篇 |
2020年 | 91篇 |
2019年 | 146篇 |
2018年 | 160篇 |
2017年 | 104篇 |
2016年 | 110篇 |
2015年 | 137篇 |
2014年 | 196篇 |
2013年 | 377篇 |
2012年 | 172篇 |
2011年 | 166篇 |
2010年 | 184篇 |
2009年 | 165篇 |
2008年 | 189篇 |
2007年 | 242篇 |
2006年 | 195篇 |
2005年 | 173篇 |
2004年 | 111篇 |
2003年 | 110篇 |
2002年 | 114篇 |
2001年 | 87篇 |
2000年 | 70篇 |
1999年 | 62篇 |
1998年 | 49篇 |
1997年 | 45篇 |
1996年 | 57篇 |
1995年 | 36篇 |
1994年 | 41篇 |
1993年 | 33篇 |
1992年 | 51篇 |
1991年 | 41篇 |
1990年 | 31篇 |
1989年 | 38篇 |
1988年 | 36篇 |
1987年 | 36篇 |
1986年 | 24篇 |
1985年 | 26篇 |
1984年 | 63篇 |
1983年 | 38篇 |
1982年 | 38篇 |
1981年 | 32篇 |
1980年 | 32篇 |
1979年 | 34篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1975年 | 9篇 |
1974年 | 11篇 |
1973年 | 13篇 |
排序方式: 共有4459条查询结果,搜索用时 218 毫秒
71.
Daniel R. Mayer Walter Kosmus Helmut Pogglitsch David mayer Wolfgang Beyer 《Biological trace element research》1993,37(1):27-38
Serum arsenic concentrations of persons suffering from renal failure and undergoing hemodialysis treatment (n=85) and of healthy controls (n=25) were determined by hydride-generation AAS technique after microwave digestion. The results were evaluated by comparing
the values of both groups, considering physiological factors and individual data, as well as comorbid conditions of the hemodialysis
(HD) patients. Serum arsenic levels were diminished in the patient group compared with controls (mean values 8.5±1.8 ng/mL
vs 10.6±1.3 ng/mL). Furthermore, additional diseases within the hemodialysis group, particularly injuries of the central nervous
system (CNS), vascular diseases, and cancer, were correlated to occasionally markedly decreased serum arsenic concentrations.
It was concluded that arsenic homeostasis is disturbed by HD treatment and certain additional diseases. Desirable arsenic
concentrations in the body seem to be reasonable. This consideration results in the conclusion that arsenic could play an
essential role in human health. Thus, reference arsenic concentrations in different human tissues and body fluids should be
established in order to recognize not only arsenic intoxication, but also arsenic deficiency. Perhaps arsenic deficiency contributes
to the increased death risk of HD patients, and therefore, arsenic supplementations for patients with extremely low serum
arsenic concentrations should be taken into account. 相似文献
72.
Cobalt determinations in biological fluids are of great interest in biological or toxicological research programs. Cobalturia
is often chosen as an indicator for a biological monitoring program in occupational exposure to cobalt dusts. The method described
here derives from the IUPAC reference method for nickel determination. It enables cobaltemia and cobalturia to be measured
in small samples (1 mL). The mean usual values for cobalt in biological fluids are very low (2.7 nmol L−1 for serum and 6.7 nmol L−1 for urine), and therefore, thus require an analytical procedure with preconcentration and extraction. The sample is mineralized
by wet acid digestion. After digestion, inorganic cobalt is extracted in form of ammonium pyrrolidine dithiocarbamate complex
into isobutyl methyl ketone and measured in the organic layer by electrothermal atomic absorption spectrometry.
The analytical parameters are described in detail. The extraction output is about 99%. The detection limits are 1.93 and 1.89
nmol L−1 for serum and urine, respectively. Sensitivity (expressed as the concentration that gives a 0.044 absorbance) is 3.4 nmol
L−1 for serum and 3.3 nmol L−1 for urine.
Within-run precision ranged between 3.9 and 2.5% (coefficients of variation) for serum and 4.2 and 1.1% for urine, at 87 and
136 nmol L−1 levels, respectively. Between-run precision ranged between 4.3 and 3.3% (coefficients of variation) for serum and 4.2 and
2.3% for urine, at 87 and 136 nmol L−1 levels, respectively. At very low concentration, 5.7 nmol L−1 for serum and 2.5 nmol L−1 for urine, the between-run precision is, respectively, 19.5 and 28%.
Linearity is effective between 0 and 272 nmol L−1. Interferences and matrix effects are negligible for urine, serum, or plasma samples without hemoglobin. The method is easily
applicable for routine determinations. 相似文献
73.
A non-detergent photosystem II preparation, named BS, has been characterized by countercurrent distribution, light saturation curves, absorption spectra and fluorescence at room and at low temperature (–196°C). The BS fraction is prepared by a sonication-phase partitioning procedure (Svensson P and Albertsson P-Å, Photosynth Res 20: 249–259, 1989) which removes the stroma lamellae and the margins from the grana and leaves the appressed partition region intact in the form of vesicles. These are closed structures of inside-out conformation. They have a chlorophyll a/b ratio of 1.8–2.0, have a high oxygen evolving capacity (295 mol O2 per mg chl h), are depleted in P700 and enriched in the cytochrome b/f complex. They have about 2 Photosystem II reaction centers per 1 cytochrome b/f complex.The plastoquinone pool available for PS II in the BS vesicles is 6–7 quinones per reaction center, about the same as for the whole thylakoid. It is concluded, therefore, that the plastoquinone of the stroma lamellae is not available to the PS II in the grana and that plastoquinone does not act as a long range electron transport shuttler between the grana and stroma lamellae.Compared with Photosystem II particles prepared by detergent (Triton X-100) treatment, the BS vesicles retain more cytochrome b/f complex and are more homogenous in their surface properties, as revealed by countercurrent distribution, and they have a more efficient energy transfer from the antenna pigments to the reaction center.Abbreviations DCMU
3-(3,4-dichlorophenyl)-1,1-dimethylurea
- Fv
variable fluorescence
- LHC
light-harvesting complex
- PpBQ
phenyl-p-benzoquinone
- PQ
plastoquinone pool
- P700
reaction center of PS I
- PS I, PS II
Photosystem I, II
- QA
first bound plastoquinone accepter
- RC
reaction centre 相似文献
74.
本文应用系统分析方法,建立了一种一级吸收药物的生物利用度的简便估计的两点法。这种方法,只需测量血管内和血管外给药后的两个相同时点的血药浓度值。不论该药的处置系统是多少室,均能得到较好的结果。这种方法不仅比目前常用的点一点法和点一面法简单,而且结果更精确。 相似文献
75.
Ross M. Welch Wendell A. Norvell Stephen C. Schaefer Jon E. Shaff Leon V. Kochian 《Planta》1993,190(4):555-561
We investigated the effects of Fe and Cu status of pea (Pisum sativum L.) seedlings on the regulation of the putative root plasma-membrane Fe(III)-chelate reductase that is involved in Fe(III)-chelate reduction and Fe2+ absorption in dicotyledons and nongraminaceous monocotyledons. Additionally, we investigated the ability of this reductase system to reduce Cu(II)-chelates as well as Fe(III)-chelates. Pea seedlings were grown in full nutrient solutions under control, -Fe, and -Cu conditions for up to 18 d. Iron(III) and Cu(II) reductase activity was visualized by placing roots in an agarose gel containing either Fe(III)-EDTA and the Fe(II) chelate, Na2bathophenanthrolinedisulfonic acid (BPDS), for Fe(III) reduction, or CuSO4, Na3citrate, and Na2-2,9-dimethyl-4,7-diphenyl-1, 10-phenanthrolinedisulfonic acid (BCDS) for Cu(II) reduction. Rates of root Fe(III) and Cu(II) reduction were determined via spectrophotometric assay of the Fe(II)-BPDS or the Cu(I)-BCDS chromophore. Reductase activity was induced or stimulated by either Fe deficiency or Cu depletion of the seedlings. Roots from both Fe-deficient and Cu-depleted plants were able to reduce exogenous Cu(II)-chelate as well as Fe(III)-chelate. When this reductase was induced by Fe deficiency, the accumulation of a number of mineral cations (i.e., Cu, Mn, Fe, Mg, and K) in leaves of pea seedlings was significantly increased. We suggest that, in addition to playing a critical role in Fe absorption, this plasma-membrane reductase system also plays a more general role in the regulation of cation absorption by root cells, possibly via the reduction of critical sulfhydryl groups in transport proteins involved in divalent-cation transport (divalent-cation channels?) across the root-cell plasmalemma. 相似文献
76.
F. Schroeder J. R. Jefferson D. Powell S. Incerpi J. K. Woodford S. M. Colles S. Myers-Payne T. Emge T. Hubbell D. Moncecchi D. R. Prows C. E. Heyliger 《Molecular and cellular biochemistry》1993,123(1-2):73-83
Fatty acid-binding proteins (FABP) are abundant cytosolic proteins whose level is responsive to nutritional, endocrine, and a variety of pathological states. Although FABPs have been investigatedin vitro for several decades, little is known of their physiological function. Liver L-FABP binds both fatty acids and cholesterol. Competitive binding analysis and molecular modeling studies of L-FABP indicate the presence of two ligand binding pockets that accomodate one fatty acid each. One fatty acid binding site is identical to the cholesterol binding site. To test whether these observations obtainedin vitro were physiologically relevant, the cDNA encoding L-FABP was transfected into L-cells, a cell line with very low endogenous FABP and sterol carrier proteins. Uptake of both ligands did not differ between control cells and low expression clones. In contrast, both fatty acid uptake and cholesterol uptake were stimulated in the high expression cells. In high expression cells, uptake of fluorescent cis-parinaric acid was enhanced more than that of trans-parinaric acid. This is consistent with the preferential binding of cis-fatty acids to L-FABP but in contrast to the preferential binding of trans-parinaric acid to the L-cell plasma membrane fatty acid transporter (PMFABP). These data show that the level of cytosolic fatty acids in intact cells can regulate both the extent and specificity of fatty acid uptake. Last, sphingomyelinase treatment of L-cells released cholesterol from the plasma membrane to the cytoplasm and stimulated microsomal acyl-CoA: cholesteryl acyl transferase (ACAT). This process was accelerated in high expression cells. These observations show for the first time in intact cells that L-FABP, a protein most prevalent in liver and intestine where much fat absorption takes place, may have a role in fatty acid and cholesterol absorption.Abbreviations FABP
fatty acid-binding protein
- L-FABP
liver fatty acid-binding protein
- I-FABP
intestinal fatty acid-binding protein
- H-FABP
heart fatty acid-binding protein
- A-FABP
adipocyte fatty acid-binding protein
- PMFABP
plasma membrane fatty acid-binding protein
- SCP-2
sterol carrier protein-2
- Dehydroergosterol (DHE)
d-5,7,9(11),22-ergostatetraene-3b-ol
- cis-parinaric
acid-9Z, 11E, 13E, 15Z-octatetraenoic acid
- trans
parinaric acid, 9E, 11E, 13E, 14E-octatetraenoic acid
- BSA
bovine serum albumin
- KRH
Krebs-Ringer-Henseleit buffer 相似文献
77.
Sukriti Sacher Abhishek Mukherjee Arjun Ray 《Biological reviews of the Cambridge Philosophical Society》2023,98(4):1160-1183
Atherosclerosis is a major contributor to the onset and progression of cardiovascular disease (CVD). Cholesterol-loaded foam cells play a pivotal role in forming atherosclerotic plaques. Induction of cholesterol efflux from these cells may be a promising approach in treating CVD. The reverse cholesterol transport (RCT) pathway delivers cholesteryl ester (CE) packaged in high-density lipoproteins (HDL) from non-hepatic cells to the liver, thereby minimising cholesterol load of peripheral cells. RCT takes place via a well-organised interplay amongst apolipoprotein A1 (ApoA1), lecithin cholesterol acyltransferase (LCAT), ATP binding cassette transporter A1 (ABCA1), scavenger receptor-B1 (SR-B1), and the amount of free cholesterol. Unfortunately, modulation of RCT for treating atherosclerosis has failed in clinical trials owing to our lack of understanding of the relationship between HDL function and RCT. The fate of non-hepatic CEs in HDL is dependent on their access to proteins involved in remodelling and can be regulated at the structural level. An inadequate understanding of this inhibits the design of rational strategies for therapeutic interventions. Herein we extensively review the structure–function relationships that are essential for RCT. We also focus on genetic mutations that disturb the structural stability of proteins involved in RCT, rendering them partially or completely non-functional. Further studies are necessary for understanding the structural aspects of RCT pathway completely, and this review highlights alternative theories and unanswered questions. 相似文献
78.
80.
Examination of the method for measuring soil respiration in cultivated land: Effect of carbon dioxide concentration on soil respiration 总被引:7,自引:1,他引:6
Toshie Nakadai Hiroshi Koizumi Youzou Usami Mitsumasa Satoh Takehisa Oikawa 《Ecological Research》1993,8(1):65-71
An acceleration of soil respiration with decreasing CO2 concentration was suggested in the field measurements. The result supporrs that obtained in laboratory experiments in our
previous study. The CO2 concentrations in a chamber of the alkali absorption method (the AA-method) were about 150–250 parts/106 lower than that in the atmosphere (about 350 parts/106), while those observed in the open-flow IRGA method (the OF-method) were nearly equal to the soil surface CO2 levels. The AA-method at such low CO2 levels in the chamber appears to overestimate the soil respiration. Our results showed that the rates obtained by the AA-method
were about twice as large as those by the OF-method in field and laboratory measurements. This finding has important consequences
with respect to the validity of the existing data obtained by the AA-method and the estimation of changes in the terrestrial
carbon flow with elevated CO2 相似文献